Arbor Biotechnologies, Inc.

5 articles with Arbor Biotechnologies, Inc.

• 

  Let's Make a Deal: Veracyte & J&J, Vertex & Arbor, Esperion & Daiichi Sankyo ...

  1/4/2019

  With the holidays over and the JP Morgan Healthcare Conference next week, companies were clearly revving their engines, ready to race into the new year. Here’s a roundup of some of the top deals that were announced today.

• Vertex and Arbor Biotechnologies Establish Collaboration to Discover Novel Proteins to Advance Discovery of Gene-Editing Therapies

  1/3/2019

  Multi-year research collaboration funded by Vertex using Arbor’s proprietary research platform to enhance efforts in developing gene-editing therapies in five diseases

• NuProbe Forms Scientific Advisory Board and Appoints New Director

  7/24/2018

  ​NuProbe Global announced today the formation of its Scientific Advisory Board (SAB) with genomics pioneers George M. Church, Ph.D. and David R. Walt, Ph.D.

• 

  Arbor Biotechnologies Comes Out of Stealth Mode

  3/16/2018

  Arbor Biotechnologies came out of stealth mode yesterday with a $15.6 million Series A financing round.

• CRISPR Pioneer And Fellow High-Profile Scientists Launch New Cambridge Startup Arbor Biotech

  6/9/2017